0.442
Precedente Chiudi:
$0.447
Aprire:
$0.46
Volume 24 ore:
513.83K
Relative Volume:
0.09
Capitalizzazione di mercato:
$13.10M
Reddito:
-
Utile/perdita netta:
$-14.58M
Rapporto P/E:
-0.3843
EPS:
-1.15
Flusso di cassa netto:
$-9.80M
1 W Prestazione:
-1.56%
1M Prestazione:
-29.67%
6M Prestazione:
-49.29%
1 anno Prestazione:
-80.09%
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Nome
Acurx Pharmaceuticals Inc
Settore
Industria
Telefono
917-533-1469
Indirizzo
259 LIBERTY AVENUE, STATEN ISLAND
Confronta ACXP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ACXP
Acurx Pharmaceuticals Inc
|
0.442 | 14.22M | 0 | -14.58M | -9.80M | -1.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
Acurx Pharmaceuticals Earnings: Antibiotic Developer to Reveal Q2 2025 Results and Pipeline Progress - Stock Titan
What analysts say about Acurx Pharmaceuticals Inc. stockFree Stock Market Query - Autocar Professional
What drives Acurx Pharmaceuticals Inc. stock priceHigh-velocity capital appreciation - Autocar Professional
Is Acurx Pharmaceuticals Inc. a good long term investmentAccelerated wealth expansion - jammulinksnews.com
Acurx Pharmaceuticals Inc. Stock Analysis and ForecastSignificant capital appreciation - jammulinksnews.com
How Acurx Pharmaceuticals Inc. stock performs during market volatility3x Return Stock Radar - Newser
What risks could impact Acurx Pharmaceuticals Inc. stock performanceFree Stock Market Analysis Courses - Newser
Acurx Pharmaceuticals Holds Annual Meeting and Elections - TipRanks
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting - Investing.com Australia
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting By Investing.com - Investing.com South Africa
Acurx Pharmaceuticals files $50M mixed shelf offering - MSN
Acurx Files to Sell 9.16M Shares of Common Stock for Holders - AInvest
What makes Acurx Pharmaceuticals Inc. stock price move sharplyFree Exclusive Group - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser
Acurx Pharmaceuticals (NASDAQ:ACXP) Stock Price Up 3.6% – Here’s Why - Defense World
ACXP SEC FilingsAcurx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ACXP raises $2.3M via warrant inducement, issues 9.1M new warrants - Stock Titan
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year? - Yahoo Finance
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Investors Purchase Large Volume of Acurx Pharmaceuticals Call Options (NASDAQ:ACXP) - Defense World
Acurx Pharmaceuticals Raises Fresh $2.67M Capital: New Antibiotic Development Gets Major Funding Boost - Stock Titan
/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./ - Yahoo Finance
Acurx Pharmaceuticals Inc (ACXP) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Crude Oil Rises Sharply; Jabil Earnings Top Views - Benzinga
US Stocks Lower; Retail Sales Decline In May - Benzinga
Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside - FinancialContent
Acurx Pharmaceuticals Soars as Breakthrough Antibiotic Data Hits the Headlines - RagingBull
Banco Santander S.A. ADR Inc. (SAN) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):